![Obesities | Free Full-Text | Mirabegron and Physical Exercise Is a Potential Strategical for BAT Activation in Obesity Obesities | Free Full-Text | Mirabegron and Physical Exercise Is a Potential Strategical for BAT Activation in Obesity](https://www.mdpi.com/obesities/obesities-02-00032/article_deploy/html/images/obesities-02-00032-g001.png)
Obesities | Free Full-Text | Mirabegron and Physical Exercise Is a Potential Strategical for BAT Activation in Obesity
![IJMS | Free Full-Text | Investigation of the Antiremodeling Effects of Losartan, Mirabegron and Their Combination on the Development of Doxorubicin-Induced Chronic Cardiotoxicity in a Rat Model IJMS | Free Full-Text | Investigation of the Antiremodeling Effects of Losartan, Mirabegron and Their Combination on the Development of Doxorubicin-Induced Chronic Cardiotoxicity in a Rat Model](https://www.mdpi.com/ijms/ijms-23-02201/article_deploy/html/images/ijms-23-02201-g001-550.jpg)
IJMS | Free Full-Text | Investigation of the Antiremodeling Effects of Losartan, Mirabegron and Their Combination on the Development of Doxorubicin-Induced Chronic Cardiotoxicity in a Rat Model
![Medica RCP |Betmiga | Indications | Side Effects | Composition | Route | all.price | Alternative Products Medica RCP |Betmiga | Indications | Side Effects | Composition | Route | all.price | Alternative Products](https://medicarcp.com/website/images/Products_RectangleFlat/7733%20-%201.jpg)
Medica RCP |Betmiga | Indications | Side Effects | Composition | Route | all.price | Alternative Products
![MEGATAS Er Tablet Mirabegron 25mg at best price in Vadodara by Medicon Lifesciences | ID: 23091274130 MEGATAS Er Tablet Mirabegron 25mg at best price in Vadodara by Medicon Lifesciences | ID: 23091274130](http://5.imimg.com/data5/SELLER/Default/2021/1/ES/OT/BZ/8565566/megatas-25-mirabegron-extended-release-tablets-25mg.jpeg)
MEGATAS Er Tablet Mirabegron 25mg at best price in Vadodara by Medicon Lifesciences | ID: 23091274130
![Efficacy, safety, and tolerability of mirabegron in patients aged ≥65 yr with overactive bladder wet: a phase IV, double-blind, randomised, placebo-controlled study (PILLAR) - ScienceDirect Efficacy, safety, and tolerability of mirabegron in patients aged ≥65 yr with overactive bladder wet: a phase IV, double-blind, randomised, placebo-controlled study (PILLAR) - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0302283819307687-gr2.jpg)